Selective expression of progesterone receptor in malignant melanoma was inversely correlated with PCNA

Abstract

To investigate the role of progesterone receptor (PR) expression in malignant melanoma (MM), PR and proliferative cell nuclear antigen (PCNA) expression were immunohistochemistrically evaluated in a series of 35 specimens of MM, and the correlation between the immunohistochemistrical findings and clinicopathological data was also analyzed. PR expression was detected in 25.7% (9/35) of the patients with MM. No PR expression was observed in nevi. PR expression was inversely correlated with PCNA expression (r=−0.353, P=0.026). PR expression was slightly increased in females, subjects aged under 55 y, those with ulceration, non-acral subtype and diagnosis delay longer than 1 y, but the difference was not statistically significant. Selective expression of progesterone receptor in malignant melanoma might be correlated with inhibited tumor growth.

Keywords

malignant melanoma / progesterone receptor

References

[1] NeifeldJ. P.. Endocrinology of melanoma. Semin Surg Oncol, 1996, 12(6): 402-406

[2] KandaN., WatanabeS.. 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol, 2001, 117(2): 274-283

[3] PacheM., Glatz-KriegerK., SauterG., et al.. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva. Graefe’s Arch Clin Exp Ophthalmol, 2006, 244(1): 113-117

[4] O’MearaA. T., CressR., XingG., et al.. Malignant melanoma in pregnancy. A population-based evaluation. Cancer, 2005, 103(6): 1217-1226

[5] WangH. W., WangJ. B., ManX. H., et al.. Detection of estrogen and progestogen receptor in patients with malignant melanoma. Chin J Dermatol (Chinese), 2003, 36(6): 346